Technology

AI industry sees prosperous future in China

Published

2 years ago

June 4, 2024

BEIJING, June 4, 2024 /PRNewswire/ — A report from People’s Daily: The application of rubber seal strips onto a car roof was accompanied by a captivating display of a huge robotic arm picking it up and rotating it mid-air. This interesting scene was unfolded at a 5G-Advanced (5G-A) flexible production line in a factory of China’s carmaker Great Wall Motors (GWM) in Baoding, north China’s Hebei province.

Thanks to the integration of 5G-A and artificial intelligence (AI), this efficient production line has slashed 60 hours of downtime per year, thus avoiding potential losses of over 800 million yuan ($110.36 million) that could have been incurred by delayed deliveries.

In recent years, China has made significant strides in AI development, marked by steady growth in industrial scale, robust infrastructure, and a rapid increase of innovative products.

“The vast application scenarios, huge market, and massive talent pool have laid a solid foundation for the vigorous development of China’s AI industry,” said Yu Youcheng, deputy secretary-general of the Chinese Association for Artificial Intelligence (CAAI).

According to Yu, a large number of new breakthroughs, technologies and applications are rapidly emerging across different application scenarios in China.

Gradual improvement in infrastructure — In 2023, the total size of China’s data center racks reached 8.1 million and the scale of computing power reached 230 EFLOPS. In particular, the scale of intelligent computing power has reached 70 EFLOPS, an increase of over 70 percent.

Steady growth in industrial scale — The total scale of China’s core AI industry has reached 500 billion yuan, and the number of related enterprises has exceeded 4,400. According to a report released by CCID Consulting, a market research firm affiliated with China Center for Information Industry Development (CCID), the market scale of China’s AI industry will reach 1.73 trillion yuan by 2035, accounting for 30.6 percent of the world’s total.

Continuous expansion of integrated applications — So far, large-scale AI models developed by China have shown tremendous potential in areas such as smart mining, drug research and development, meteorology, government services, finance, intelligent manufacturing, and railway management. The integrated application of the industrial internet in China has expanded to 49 major categories of the national economy, and generative AI has been widely applied in chatting robots, intelligent search, and text generation.

At the general cargo terminal of Rizhao Port in east China’s Shandong province, a diverse array of general cargo items came together before making their way to different parts of the world, including steel plates made in Handan, north China’s Hebei province, excavators from Zhuzhou, central China’s Hunan province, and drainage pipes from Zhengzhou, the capital city of central China’s Henan province.

In the past, the complex loading and unloading procedures for these items, which varied greatly in shape and size, resulted in low operational efficiency. Now, with an AI-enabled planning system, the port has boosted its overall operational efficiency by 10 percent and yard throughput by 20 percent.

Apart from assisting intelligent manufacturing, AI technology can also make typhoon forecasts, develop new drugs, identify faults, and formulate production plans. These remarkable breakthroughs are paving the way for an era of intelligence.

The application of AI technology in the transportation sector has enhanced operational efficiency and raised safety levels.

In Changsha, the capital city of Hunan province, buses have been connected to an intelligent traffic control system managed by the traffic police. When a bus approaches an intersection, the traffic signal will automatically switch to green, allowing the bus to have priority passage.

“Smart public transportation saves commuting time by 30.7 percent on average compared to regular transportation modes,” said Liu Gao, a project leader of Xiangjiang Smart Tech Innovation Center. So far, 75 routes in downtown Changsha have gone through intelligent transformation, Liu added.

AI technology has also made scientific research more efficient. Chinese software company Kingsoft has unveiled a one-stop office productivity platform powered by AI, which can analyze data as well as reading and recognizing Chinese characters, serving as a “well-rounded” digital employee.

While applied in experiments, AI technologies can significantly save the time needed for scientific research. For instance, Baidu AI Cloud and Shanghai Jiao Tong University have jointly developed an open-source platform for scientific data, which can accelerate the entire chain of chemical synthesis, ranging from molecular design and reaction design to condition generation and reaction testing. This platform can reduce the time required for designing potential functional molecules, such as drug molecules and their synthesis plans, from several months to just dozens of minutes.

In the face of the booming development of the AI industry, many experts and business leaders have highlighted the importance of accelerating AI-related sci-tech innovation and promoting high-quality development and high-level application of AI in order to foster new growth drivers.

Moving forward, China will continue to enhance AI infrastructure, expand AI applications, and advance key and core AI technologies to bring its AI industry onto a higher level.

View original content:https://www.prnewswire.com/apac/news-releases/ai-industry-sees-prosperous-future-in-china-302163353.html

SOURCE People’s Daily

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

36 minutes ago

April 23, 2026

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

36 minutes ago

April 23, 2026

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

36 minutes ago

April 23, 2026

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system, helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company